The Robert H. Lurie Comprehensive Cancer Center (Lurie Cancer Center) of Northwestern University was added as a second site in a clinical trial combining the LIXTE’s proprietary compound LB-100 with ...
VANCOUVER, British Columbia, April 02, 2026--$79 million investment from Government of Canada supports $280 million project ...
State Superintendent Mo Green says ‘perhaps it’s the case that North Carolina’s public schools have never been better.’ ...
LIXTE Biotechnology Holdings, Inc. ("LIXTE" or the "Company") (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing ...
A new biosensor developed at the Department of Energy's Oak Ridge National Laboratory detects the emerging presence of fungus ...
Strasbourg, France & Schiphol, Netherlands, April 2, 2026, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs ...
ONCOMATRYX, a Spanish biopharmaceutical company developing Quantum ADCs against the tumor microenvironment, has successfully raised $67 million to foster the clinical development of novel candidates.
From legacy therapeutics to next-generation GLP-1s, advances in synthesis, analysis, and regulation are reshaping how peptide ...
Beta-cyclodextrin remains the most widely produced and commercially used form, largely because of its favorable cavity size, relatively low production cost, and well-documented safety profile.
Learn how synthetic promoters bring innovation to gene expression, enhancing performance and safety in biotechnology ...
As the conflict in Iran continues, locally, farmers are or will soon be feeling the effects, specifically when it comes to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results